Safety and Efficacy of Intravenous Tirofiban as Antiplatelet Premedication for Stent-Assisted Coiling in Acutely Ruptured Intracranial Aneurysms

References

1. 1.↵
   2. Molyneux AJ,
   3. Kerr RS,
   4. Yu LM, et al

   . International subarachnoid aneurysm trial (ISAT) of neurosurgical clipping versus endovascular coiling in 2143 patients with ruptured intracranial aneurysm: a randomised comparison of effects on survival, dependency, seizures, rebleeding, subgroups, and aneurysm occlusion. Lancet 2005;366:809–17 doi:10.1016/S0140-6736(05)67214-5 pmid:16139655

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Benitez RP,
   3. Silva MT,
   4. Klem J, et al

   . Endovascular occlusion of wide-necked aneurysms with a new intracranial microstent (Neuroform) and detachable coils. Neurosurgery 2004;54:1359–67; discussion 1368 doi:10.1227/01.NEU.0000124484.87635.CD pmid:15157292

   CrossRefPubMedWeb of Science
3. 3.↵
   2. Fiorella D,
   3. Albuquerque FC,
   4. Han P, et al

   . Preliminary experience using the Neuroform stent for the treatment of cerebral aneurysms. Neurosurgery 2004;54:6–16; discussion 16–17 doi:10.1227/01.NEU.0000097194.35781.EA pmid:14683536

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Piotin M,
   3. Blanc R,
   4. Spelle L, et al

   . Stent-assisted coiling of intracranial aneurysms: clinical and angiographic results in 216 consecutive aneurysms. Stroke 2010;41:110–15 doi:10.1161/STROKEAHA.109.558114 pmid:19959540

   CrossRefPubMed
5. 5.↵
   2. Jeong HW,
   3. Jin SC

   . Intra-arterial infusion of a glycoprotein IIb/IIIa antagonist for the treatment of thromboembolism during coil embolization of intracranial aneurysm: a comparison of abciximab and tirofiban. AJNR Am J Neuroradiol 2013;34:1621–25 doi:10.3174/ajnr.A3501 pmid:23660289

   Abstract/FREE Full Text
6. 6.↵
   2. Aggour M,
   3. Pierot L,
   4. Kadziolka K, et al

   . Abciximab treatment modalities for thromboembolic events related to aneurysm coiling. Neurosurgery 2010;67(2 suppl operative):503–08 doi:10.1227/NEU.0b013e3181f8d1db pmid:21099579

   CrossRefPubMed
7. 7.↵
   2. Yi HJ,
   3. Gupta R,
   4. Jovin TG, et al

   . Initial experience with the use of intravenous eptifibatide bolus during endovascular treatment of intracranial aneurysms. AJNR Am J Neuroradiol 2006;27:1856–60 pmid:17032856

   Abstract/FREE Full Text
8. 8.↵
   2. Dawson P,
   3. Strickland NH

   . Thromboembolic phenomena in clinical angiography; role of materials and technique. J Vasc Interv Radiol 1991;2:125–32 doi:10.1016/S1051-0443(91)72485-88 pmid:1799742

   CrossRefPubMed
9. 9.↵
   2. Pierot L,
   3. Spelle L,
   4. Vitry F

   . Immediate clinical outcome of patients harboring unruptured intracranial aneurysms treated by endovascular approach: results of the ATENA study. Stroke 2008;39:2497–504 doi:10.1161/STROKEAHA.107.512756 pmid:18617659

   Abstract/FREE Full Text
10. 10.↵
    2. Bodily KD,
    3. Cloft HJ,
    4. Lanzino G, et al

    . Stent-assisted coiling in acutely ruptured intracranial aneurysms: a qualitative, systematic review of the literature. AJNR Am J Neuroradiol 2011;32:1232–36 doi:10.3174/ajnr.A2478 pmid:21546464

    Abstract/FREE Full Text
11. 11.↵
    2. Meckel S,
    3. Singh TP,
    4. Undrén P, et al

    . Endovascular treatment using predominantly stent-assisted coil embolization and antiplatelet and anticoagulation management of ruptured blood blister-like aneurysms. AJNR Am J Neuroradiol 2011;32:764–71 doi:10.3174/ajnr.A2392 pmid:21372169

    Abstract/FREE Full Text
12. 12.↵
    2. Ries T,
    3. Buhk JH,
    4. Kucinski T, et al

    . Intravenous administration of acetylsalicylic acid during endovascular treatment of cerebral aneurysms reduces the rate of thromboembolic events. Stroke 2006;37:1816–21 doi:10.1161/01.STR.0000226933.44962.a6 pmid:16778126

    Abstract/FREE Full Text
13. 13.↵
    2. Müller I,
    3. Seyfarth M,
    4. Rüdiger S, et al

    . Effect of a high loading dose of clopidogrel on platelet function in patients undergoing coronary stent placement. Heart 2001;85:92–93 doi:10.1136/heart.85.1.92 pmid:11119474

    FREE Full Text
14. 14.↵
    2. Park JH,
    3. Kim JE,
    4. Sheen SH, et al

    . Intraarterial abciximab for treatment of thromboembolism during coil embolization of intracranial aneurysms: outcome and fatal hemorrhagic complications. J Neurosurg 2008;108:450–57 doi:10.3171/JNS/2008/108/3/0450 pmid:18312090

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Walsh RD,
    3. Barrett KM,
    4. Aguilar MI, et al

    . Intracranial hemorrhage following neuroendovascular procedures with abciximab is associated with high mortality: a multicenter series. Neurocrit Care 2011;15:85–95 doi:10.1007/s12028-010-9338-1 pmid:20169473

    CrossRefPubMedWeb of Science
16. 16.↵
    2. Cho YD,
    3. Lee JY,
    4. Seo JH, et al

    . Early recurrent hemorrhage after coil embolization in ruptured intracranial aneurysms. Neuroradiology 2012;54:719–26 doi:10.1007/s00234-011-0950-3 pmid:21969241

    CrossRefPubMedWeb of Science
17. 17.↵
    2. Tcheng JE,
    3. Ellis SG,
    4. George BS, et al

    . Pharmacodynamics of chimeric glycoprotein IIb/IIIa integrin antiplatelet antibody Fab 7E3 in high-risk coronary angioplasty. Circulation 1994;90:1757–64 doi:10.1161/01.CIR.90.4.1757 pmid:7923659

    Abstract/FREE Full Text
18. 18.↵
    2. McCuigan MA,
    3. Caravati EM

    1. Dart RC

    ed, McCuigan MA, Caravati EM. Medical Toxicology. 3rd ed. Philadelphia: Lippincott, Williams & Wilkins; 2003:635–37
19. 19.↵
    Highlights of prescribing information: AGGRASTAT (tirofiban hydrochloride). Food and Drug Administration, Silver Spring, Maryland. http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020912s019s020lbl.pdf. Accessed August 7, 2015.
20. 20.↵
    2. Chalouhi N,
    3. Jabbour P,
    4. Kung D, et al

    . Safety and efficacy of tirofiban in stent-assisted coil embolization of intracranial aneurysms. Neurosurgery 2012;71:710–14; discussion 714 doi:10.1227/NEU.0b013e31826213f9 pmid:22668886

    CrossRefPubMed
21. 21.↵
    2. Lodi YM,
    3. Latorre JG,
    4. El-Zammar Z, et al

    . Stent assisted coiling of the ruptured wide necked intracranial aneurysm. J Neurointerv Surg 2012;4:281–86 doi:10.1136/neurintsurg-2011-010035 pmid:21990500

    Abstract/FREE Full Text
22. 22.↵
    2. Roitberg BZ,
    3. Khan N,
    4. Alp MS, et al

    . Bedside external ventricular drain placement for the treatment of acute hydrocephalus. Br J Neurosurg 2001;15:324–27 doi:10.1080/02688690120072478 pmid:11599448

    CrossRefPubMed
23. 23.↵
    2. Ehtisham A,
    3. Taylor S,
    4. Bayless L, et al

    . Placement of external ventricular drains and intracranial pressure monitors by neurointensivists. Neurocrit Care 2009;10:241–47 doi:10.1007/s12028-008-9097-4 pmid:18449808

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Binz DD,
    3. Toussaint LG 3rd.,
    4. Friedman JA

    . Hemorrhagic complications of ventriculostomy placement: a meta-analysis. Neurocrit Care 2009;10:253–56 doi:10.1007/s12028-009-9193-0 pmid:19224404

    CrossRefPubMedWeb of Science
25. 25.↵
    2. Scholz C,
    3. Hubbe U,
    4. Deininger M, et al

    . Hemorrhage rates of external ventricular drain (EVD), intracranial pressure gauge (ICP) or combined EVD and ICP gauge placement within 48 h of endovascular coil embolization of cerebral aneurysms. Clin Neurol Neurosurg 2013;115:1399–402 doi:10.1016/j.clineuro.2013.01.023 pmid:23428140

    CrossRefPubMed
26. 26.↵
    2. Kung DK,
    3. Policeni BA,
    4. Capuano AW, et al

    . Risk of ventriculostomy-related hemorrhage in patients with acutely ruptured aneurysms treated using stent-assisted coiling. J Neurosurg 2011;114:1021–27 doi:10.3171/2010.9.JNS10445 pmid:20950080

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Wiviott SD,
    3. Braunwald E,
    4. McCabe CH, et al

    ; TRITON-TIMI 38 Investigators. Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 2007;357:2001–15 doi:10.1056/NEJMoa0706482 pmid:17982182

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Gurbel PA,
    3. Bliden KP,
    4. Butler K, et al

    . Randomized double-blind assessment of the ONSET and OFFSET of the antiplatelet effects of ticagrelor versus clopidogrel in patients with stable coronary artery disease: the ONSET/OFFSET study. Circulation 2009;120:2577–85 doi:10.1161/CIRCULATIONAHA.109.912550 pmid:19923168

    Abstract/FREE Full Text
29. 29.↵
    2. Zhu B,
    3. Effron MB,
    4. Kulkarni MP, et al

    . The onset of inhibition of platelet aggregation with prasugrel compared with clopidogrel loading doses using gatekeeping analysis of integrated clinical pharmacology data. J Cardiovasc Pharmacol 2011;57:317–24 doi:10.1097/FJC.0b013e3182073dfb pmid:21266916

    CrossRefPubMed
30. 30.↵
    2. Kulcsár Z,
    3. Wetzel SG,
    4. Augsburger L, et al

    . Effect of flow diversion treatment on very small ruptured aneurysms. Neurosurgery 2010;67:789–93 doi:10.1227/01.NEU.0000372920.39101.55 pmid:20657324

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Aydin K,
    3. Arat A,
    4. Sencer S, et al

    . Treatment of ruptured blood blister-like aneurysms with flow diverter SILK stents. J Neurointerv Surg 2015;7:202–09 doi:10.1136/neurintsurg-2013-011090 pmid:24491271

    Abstract/FREE Full Text
32. 32.↵
    2. Chalouhi N,
    3. Zanaty M,
    4. Starke R, et al

    . O-022: a new protocol for anticoagulation with tirofiban during stenting of intracranial aneurysms. J Neurointerv Surg 2014;6:A11–12 doi:10.1136/neurintsurg-2014-011343.22

    Abstract/FREE Full Text
33. 33.↵
    AGGRASTAT (tirofiban hydrochloride). MERCK & CO., INC., West Point, PA. Food and Drug Administration, Silver Spring, Maryland. http://www.accessdata.fda.gov/drugsatfda_docs/label/1998/20913lbl.pdf. Accessed August 8, 2015.